Skip to main content
. 2017 Jun;6(3):517–528. doi: 10.21037/tau.2017.04.42

Table 7. Health-related quality of life at baseline and at week 12.

HRQoL questionaire and scale Week 0 Week 12 P
Median Q1 Q3 Median Q1 Q3
QLQ-C30
   Global health scale
      Global health 83 73 100 83 67 92 0.12
   Functional scales
      Physical 93 80 100 83 73 93 0.006
      Role 100 83 100 92 67 100 0.15
      Emotional 100 92 100 100 83 100 0.09
      Cognitive 100 96 100 100 83 100 0.41
      Social 100 100 100 100 100 100 0.34
   Symptom scales
      Fatigue 11 0 22 11 0 25 0.80
      Nausea/vomiting 0 0 0 0 0 0 0.17
      Pain 0 0 33 0 0 21 0.67
      Dyspnea 0 0 33 0 0 0 0.76
      Sleep disturbance 0 0 8 0 0 8 0.78
      Appetite loss 0 0 0 0 0 0 0.07
      Constipation 0 0 0 0 0 0 0.71
      Diarrhea 0 0 0 0 0 0 NA
      Financial impact 0 0 0 0 0 0 NA
QLQ-PR25
   Functional scales
      Sexual activity 0 0 17 0 0 0 0.50
      Sexual functioning Not reported, n=3 Not reported, n=2 NA
   Symptom scales
      Urinary symptoms 19 13 34 19 13 39 0.41
      Bowel symptoms 0 0 17 0 0 8 0.28
      Hormonal treatment-related symptoms 17 11 28 17 11 22 0.29
      Incontinence aid (n=3) 17 8 25 17 8 25 NA

The P values were calculated using the Wilcoxon signed-rank test. QLQ-C30, quality-of-life core 30; QLQ-PR25, quality of life questionnaire-Prostate Module 25; NA, not available.